Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Drug Metab Dispos. 2012 Nov;40(11):2192-203. doi: 10.1124/dmd.112.047746. Epub 2012 Aug 21.
The presence of bovine serum albumin (BSA) largely modulates the enzyme kinetics parameters of the human UDP-glucuronosyltransferase (UGT) 1A9, increasing both the apparent aglycone substrate affinity of the enzyme and its limiting reaction velocity (Drug Metab Dispos 39:2117-2129, 2011). For a better understanding of the BSA effects and an examination of whether its presence changes the catalytic mechanism, we have studied the enzyme kinetics of 4-methylumbelliferone glucuronidation by UGT1A9 in the presence and absence of 0.1% BSA, using bisubstrate enzyme kinetic experiments, in both the forward and reverse directions, as well as product and dead-end inhibition. The combined results strongly suggest that the reaction mechanism of UGT1A9, and presumably other human UGTs as well, involves the formation of a compulsory-order ternary-complex, with UDP-α-d-glucuronic acid (UDPGA) as the first binding substrate. Based on the enzyme kinetic parameters measured for the forward and reverse reactions, the equilibrium constant of the overall reaction was calculated (Keq = 574) and the relative magnitudes of the reaction rate constants were elucidated. The inclusion of BSA in the bisubstrate kinetic experiments quantitatively changed the apparent enzyme kinetic parameters, presumably by removing internal inhibitors that bind to the binary enzyme-UDPGA (E-UDPGA) complex, as well as to the ternary E-UDPGA-aglycone complex. Nevertheless, the underlying compulsory-order ternary-complex mechanism with UDPGA binding first is the same in both the absence and presence of BSA. The results offer a novel understanding of UGT enzyme kinetic mechanism and BSA effects.
牛血清白蛋白(BSA)的存在在很大程度上调节了人 UDP-葡糖醛酸基转移酶(UGT)1A9 的酶动力学参数,增加了酶的表观糖苷配基底物亲和力和限速反应速度(Drug Metab Dispos 39:2117-2129, 2011)。为了更好地理解 BSA 的影响,并研究其存在是否改变催化机制,我们使用双底物酶动力学实验,在正向和反向两个方向上,以及产物和无活力末端抑制,研究了 UGT1A9 催化 4-甲基伞形酮葡糖苷酸化时在存在和不存在 0.1%BSA 情况下的酶动力学。综合结果强烈表明,UGT1A9 的反应机制,大概还有其他人类 UGT 也是如此,涉及形成一个强制顺序的三元复合物,UDP-α-d-葡糖醛酸(UDPGA)作为第一个结合的底物。基于正向和反向反应测量的酶动力学参数,计算了整个反应的平衡常数(Keq = 574),并阐明了反应速率常数的相对大小。在双底物动力学实验中加入 BSA 定量改变了表观酶动力学参数,可能是通过去除与二元酶-UDPGA(E-UDPGA)复合物以及三元 E-UDPGA-糖苷配基复合物结合的内部抑制剂。然而,在没有和存在 BSA 的情况下,UDPGA 结合首先的强制顺序三元复合物机制是相同的。这些结果提供了对 UGT 酶动力学机制和 BSA 影响的新认识。